Track topics on Twitter Track topics that are important to you
Novartis has launched what it claims is the first large-scale mobile research study which will gather data on multiple sclerosis (MS) from patients via their smartphones, removing the need for them to visit a medical professional at the clinic.
The study, known as ‘Evaluation of evidence from smart phone sensors and patient-reported outcomes in participants with multiple sclerosis’, or elevateMS, is designed to gather data on the challenges faced by sufferers of MS on a daily basis, in order to develop more effective gauges of treatment effectiveness.NEXT ARTICLE
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...
Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...